Cargando…
Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
Type 2 diabetes is often associated with arterial atherosclerosis in large blood vessels. We set out to elucidate whether commonly used antidiabetic drugs metformin, sitagliptin, and pioglitazone will reduce atherosclerosis in T2DM patients. We enrolled 176 individuals with type 2 diabetes, which we...
Autores principales: | Liu, Xiaojie, Mei, Tao, Chen, Wei, Ye, Shandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429949/ https://www.ncbi.nlm.nih.gov/pubmed/28539704 http://dx.doi.org/10.1155/2017/5032708 |
Ejemplares similares
-
The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis
por: Stefanidis, I., et al.
Publicado: (2018) -
Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice
por: Ji, Pengmin, et al.
Publicado: (2023) -
Serum Pentosidine is Associated with Cardiac Dysfunction and Atherosclerosis in T2DM
por: Cao, Yuyan, et al.
Publicado: (2023) -
Effect of variable antidiabetic treatments strategy on oxidative stress markers in obese patients with T2DM
por: ALrefai, Abeer A., et al.
Publicado: (2017) -
Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM
por: Guclu, Metin, et al.
Publicado: (2015)